ArticleEuropean journal of medical research2025
The application of various carbon nanoparticle injection methods in sentinel lymph node mapping for colorectal cancer.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of carbon nanoparticle suspension in sentinel lymph nodes biopsy for acral melanoma.World journal of surgical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aims to investigate the application strategy of "single point-point pressure method" and multi-point injection techniques for carbon nanoparticle injection in laparoscopic radical resection of rectal cancer. The focus is on evaluating the efficacy and efficiency of both methods in sentinel lymph node mapping and tumor localization. PATIENTS AND
methodsA prospective analysis was conducted on a total of 119 rectal cancer cases treated our center from January 2020 to December 2021. The cases were divided into two groups: multi-point group and single-point group. In the multi-point group, multiple points of 1:1 diluted nano-carbon suspension were injected into the submucosa around the lesions. In the single-spot group, the tumor lesions were identified using electronic colonoscopy, followed by manual pressure applied to the corresponding abdominal wall. A single point of the stock solution of nano-carbon suspension was injected into the submucosa around the lesions upon observing the external pressure "bouncing sign" under the microscope.
resultsNo significant differences were observed between the multi-point group and the single-point group in terms of the number of detected lymph nodes, lesion location, distal resection margin (time to locate the tumor), carbon nanoparticles injection spatter event, operation time for middle and high rectal cancer, intraoperative blood loss, and postoperative exhaust time (P > 0.05). However, the injection time of nano-carbon and operation time for low rectal cancer were significantly shorter in the single point group, with statistically significant differences observed between the two groups (P < 0.05).
conclusionsIdentifying the distal resection margin clinically contributes to reducing operation time, simplifying surgical procedures, and enhancing efficiency. Sentinel lymph node mapping is crucial in colorectal cancer as it helps in accurate staging and treatment planning. This study aligns with previous research highlighting the effectiveness of carbon nanoparticles in improving lymph node detection and reducing operative time. In addition, this study contributes to the literature by demonstrating the efficiency of the "single point-point pressure method" in laparoscopic radical resection of rectal cancer, offering a simpler and faster alternative to multi-point injection techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.